Reprogramming macrophage by targeting VEGF and CD40 potentiates OX40 immunotherapy

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (32171468, 32271529, 82104092, 82273843, 82373898)
  • Shenzhen Municipal Fundamental Research Program (JCYJ20210324121814039)

This publication has 20 references indexed in Scilit: